Ambuja Cements Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

June 25, 2026
Posted by: Kunal Singla
Category: News

Ambuja Cements Q1 Results FY27: Uniresearch projects Revenue Rs 11,575 Cr | PAT Rs 620 Cr (40-analyst consensus). Q4 FY26: Rev Rs 10,915 Cr | PAT Rs 1,857 Cr.

The Ambuja Cements outlook is anchored on verified Q4 FY26 actuals. Uniresearch applies the 40-analyst FY27 consensus to Q1 FY26 actuals: Revenue Rs 11,575 Cr (+12.5% YoY) and PAT Rs 620 Cr (-39.0% YoY). Prepared by Ankit Jaiswal.

Click Here – Get Free Investment Predictions

Table of Contents

Ambuja Cements – Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 FY27 Uniresearch Prediction	YoY Change	Source
Ambuja Cements Revenue (Rs Cr)	10,289	11,575	+12.5%	Uniresearch \| 40-analyst FY27 consensus
PAT (Rs Cr)	1,017	620	-39.0%	Uniresearch \| 40-analyst FY27 consensus
Avg Analyst Target	Rs 513	12-month view	–	40 analysts

40-analyst FY27 consensus: Rev +12.5%, PAT -39.0%. Not guaranteed outcomes.

Ambuja Cements Q4 FY26 Key Metrics

Metric	Q4 FY26 Actual	YoY Change	Source
Revenue (Rs Cr)	10,915	+9.4% YoY	Consolidated quarterly data
PAT (Rs Cr)	1,857	+37.5% YoY	Consolidated quarterly data

Analyst Views on Ambuja Cements

The 40-analyst FY27 consensus projects revenue +12.5% and profit -39.0% for Ambuja Cements, with an average 12-month target of Rs 513.

Key Watchpoints for Ambuja Cements

Revenue Delivery

Revenue target Rs 11,575 Cr (+12.5% consensus, Q1 FY26 base Rs 10,289 Cr).

PAT vs Consensus

PAT target Rs 620 Cr (-39.0% vs Q1 FY26 actual Rs 1,017 Cr).

Risks to Ambuja Cements Prediction

Revenue Miss

Revenue below +12.5% consensus would miss the Rs 11,575 Cr target.

PAT Pressure

Margin headwinds or cost factors could affect PAT vs -39.0% consensus.

Conclusion: Ambuja Cements

Uniresearch predicts Ambuja Cements Revenue Rs 11,575 Cr and PAT Rs 620 Cr based on 40-analyst FY27 consensus. Track live updates on Univest.

Track Ambuja Cements Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live alerts.

Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions apply analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.

FAQs on Ambuja Cements

What is Uniresearch’s PAT prediction for Ambuja Cements Q1 Results FY27?

Ans. Uniresearch projects Ambuja Cements Q1 FY27 PAT at Rs 620 Cr (-39.0% consensus from Q1 FY26 base Rs 1,017 Cr).

What is the Revenue forecast for Ambuja Cements Q1 Results FY27?

Ans. Ambuja Cements Q1 FY27 Revenue projected at Rs 11,575 Cr (+12.5% from Q1 FY26 base Rs 10,289 Cr).

What were Ambuja Cements Q1 Results FY27?

Ans. Q4 FY26: Revenue Rs 10,915 Cr (+9.4% YoY), PAT Rs 1,857 Cr (+37.5% YoY).

How many analysts cover Ambuja Cements Q1 Results FY27?

Ans. The prediction uses 40-analyst FY27 consensus, avg target Rs 513.

What FY27 consensus was used for Ambuja Cements Q1 Results FY27?

Ans. Revenue +12.5% and profit -39.0% based on 40-analyst FY27 consensus.

What are risks to Ambuja Cements Q1 Results FY27?

Ans. Revenue below +12.5% consensus or PAT below -39.0% consensus are key risks.

What is the Q1 FY26 base used for Ambuja Cements Q1 Results FY27?

Ans. Q1 FY26 Revenue Rs 10,289 Cr and PAT Rs 1,017 Cr.

News Q1 results

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.